Cincinnati Children's Hospital Medical Center Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required) - Moderna Pediatric Study
辛辛那提儿童医院医疗中心疫苗和治疗评估单位(需要 UM1 临床试验)- Moderna 儿科研究
基本信息
- 批准号:10387080
- 负责人:
- 金额:$ 119.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-07 至 2022-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAgeApplied ResearchAreaCOVID-19 vaccineChildhoodClinicalClinical ResearchClinical TrialsCommunicable DiseasesConduct Clinical TrialsDevelopmentDiseaseDisease OutbreaksEnrollmentEnteralEpidemiologyEvaluationFundingGoalsGrantHumanInfectionInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H5N1 SubtypeLeadershipLettersMedical centerMicrobiologyMissionModelingMulticenter StudiesNational Institute of Allergy and Infectious DiseaseParticipantPediatric HospitalsPregnant WomenResourcesRespiratory Tract InfectionsSexually Transmitted DiseasesSiteSystems BiologyTestingU-Series Cooperative AgreementsUnited States National Institutes of HealthVaccinesclinical trial implementationenteric pathogeninfluenza virus vaccineinvestigator-initiated trialneglected tropical diseasesnovelorganizational structureparent grantpreventrecruitrespiratory pathogenresponsevaccine effectivenessvaccine trialvaccine-induced immunity
项目摘要
PROJECT SUMMARY
As a VTEU for nearly 25 years, we have provided the scientific, clinical, administrative, and organizational
structure to support implementation of clinical trials and studies for the Division of Microbiology and Infectious
Diseases (DMID) including respiratory infections, enteric diseases, sexually transmitted infections and
neglected tropical diseases. Also, we are recognized experts in the area of human challenge infection models
(CHIMs) of enteric and respiratory pathogens. Additionally we repeatedly have demonstrated the ability to
provide surge capacity to address infectious disease outbreaks as evidenced by our responses to the testing of
H5N1 and novel H1N1 influenza vaccines (for which we received a personal letter from Dr Anthony Fauci). To
further expand the capabilities of our Unit; we have added expertise in epidemiology and vaccine
effectiveness. We consistently have met or exceed enrollment goals and routinely have over 90% of our
subjects complete the study. We consistently have exceeded contractual obligations, including rapid
recruitment of subjects spanning the age spectrum including pregnant women. We have provided outstanding
leadership of multi-center studies and have been excellent collaborators on studies led by other VTEU sites.
We have developed investigator initiated trials and have assisted in the development of trials initiated by DMID.
We also have undertaken vaccine projects incorporating systems biology to more deeply understand correlates
of vaccine-induced immunity. We are extremely excited to continue as a VTEU, collaborating with the IDCRC,
the Leadership Group, NIAID, and other Infectious Diseases experts under this NIAID Cooperative Agreement.
The main focus of the parent grant is to provide funding to assemble and maintain the team needed to perform
clinical trials. The supplemental funding will provide the resources needed to conduct COVID-19 vaccine trials.
It is projected that with the supplemental funding, we will recruit, enroll and retain 90 participants over the 2
year period of the study.
项目摘要
作为近25年的VTEU,我们提供了科学,临床,行政和组织
支持微生物和传染病科实施临床试验和研究的结构
疾病(DMID),包括呼吸道感染、肠道疾病、性传播感染和
被忽视的热带病此外,我们是人类挑战感染模型领域的公认专家
(CHIMs)的肠道和呼吸道病原体。此外,我们一再证明,
提供快速部署能力,以应对传染病爆发,我们对检测
H5 N1和新型H1N1流感疫苗(我们收到了Anthony Fauci博士的私人信件)。到
进一步扩大我们单位的能力;我们增加了流行病学和疫苗方面的专门知识
有效性我们一直达到或超过招生目标,并经常有超过90%的我们的
受试者完成研究。我们一直在超越合同义务,包括快速
招募年龄范围内的受试者,包括孕妇。我们提供了出色的
领导多中心研究,并一直是其他VTEU研究中心领导的研究的优秀合作者。
我们开发了研究者发起的试验,并协助开发了DMID发起的试验。
我们还开展了疫苗项目,将系统生物学纳入其中,以更深入地了解相关因素
疫苗诱导的免疫力。我们非常高兴能继续作为VTEU,与IDCRC合作,
领导小组,NIAID,和其他传染病专家根据本NIAID合作协议。
家长补助金的主要重点是提供资金,以组装和维持所需的团队执行
临床试验补充资金将提供进行COVID-19疫苗试验所需的资源。
预计在获得补充资金的情况下,我们将在2015年招募、登记和保留90名参与者。
研究为期一年。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Wilson Frenck其他文献
Robert Wilson Frenck的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert Wilson Frenck', 18)}}的其他基金
Cincinnati Children's Hospital Medical Center Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required)
辛辛那提儿童医院医疗中心疫苗和治疗评估单位(需要 UM1 临床试验)
- 批准号:
10378359 - 财政年份:2021
- 资助金额:
$ 119.85万 - 项目类别:
Cincinnati Children's Hospital Medical Center Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required)-DMID 21-0012
辛辛那提儿童医院医疗中心疫苗和治疗评估单位(需要 UM1 临床试验)-DMID 21-0012
- 批准号:
10402467 - 财政年份:2021
- 资助金额:
$ 119.85万 - 项目类别:
Cincinnati Children's Hospital Medical Center Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required)
辛辛那提儿童医院医疗中心疫苗和治疗评估单位(需要 UM1 临床试验)
- 批准号:
10456399 - 财政年份:2021
- 资助金额:
$ 119.85万 - 项目类别:
Cincinnati Children's Hospital Medical Center Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required)
辛辛那提儿童医院医疗中心疫苗和治疗评估单位(需要 UM1 临床试验)
- 批准号:
10533270 - 财政年份:2019
- 资助金额:
$ 119.85万 - 项目类别:
Cincinnati Children's Hospital Medical Center Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required)
辛辛那提儿童医院医疗中心疫苗和治疗评估单位(需要 UM1 临床试验)
- 批准号:
10306390 - 财政年份:2019
- 资助金额:
$ 119.85万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 119.85万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 119.85万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 119.85万 - 项目类别:
Fellowship
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 119.85万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 119.85万 - 项目类别:
Continuing Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 119.85万 - 项目类别:
Standard Grant
The economics of (mis)information in the age of social media
社交媒体时代(错误)信息的经济学
- 批准号:
DP240103257 - 财政年份:2024
- 资助金额:
$ 119.85万 - 项目类别:
Discovery Projects
How age & sex impact the transcriptional control of mammalian muscle growth
你多大
- 批准号:
DP240100408 - 财政年份:2024
- 资助金额:
$ 119.85万 - 项目类别:
Discovery Projects
Supporting teachers and teaching in the age of Artificial Intelligence
支持人工智能时代的教师和教学
- 批准号:
DP240100111 - 财政年份:2024
- 资助金额:
$ 119.85万 - 项目类别:
Discovery Projects
Enhancing Wahkohtowin (Kinship beyond the immediate family) Community-based models of care to reach and support Indigenous and racialized women of reproductive age and pregnant women in Canada for the prevention of congenital syphilis
加强 Wahkohtowin(直系亲属以外的亲属关系)以社区为基础的护理模式,以接触和支持加拿大的土著和种族育龄妇女以及孕妇,预防先天梅毒
- 批准号:
502786 - 财政年份:2024
- 资助金额:
$ 119.85万 - 项目类别:
Directed Grant